England had 11,098 community pharmacies in 2024/25, the lowest count since 2015/16.
A shrinking sector doing more work
Community pharmacy is the rare sector where the demand curve and the supply curve are moving in opposite directions, and that is the whole story for anyone looking at a pharmacy for sale.
Pharmacies in England dispensed 1.16 billion prescription items in 2024/25, a 4% increase on the previous year and 16% more than the 995 million dispensed a decade earlier. Over the same period the number of community pharmacies fell to 11,098, the lowest level since 2015/16. The NHS Business Services Authority figures, published in October 2025, put the average at around 104,000 items per pharmacy across the year.
Fewer sites, more volume per site. That is a decent structural position for a surviving pharmacy and a difficult one for a marginal one, which is exactly why the sale market has behaved the way it has.
What a pharmacy for sale actually costs
Pharmacy valuation is unusual because the buyer is not really buying a customer base. Patients are attached to a location and a prescribing GP, not to the person behind the counter. What you are buying is a dispensing volume, a position on the NHS pharmaceutical list, and whatever margin the current owner has managed to hold on to.
The most useful published transaction data comes from Christie and Co, which advised on, valued or sold 1,155 pharmacies during 2025 with a combined transaction value of £869m. Two figures in that report matter more than the headline.
Average values rose in 2025, having fallen 6.3% the year before. Christie and Co attributes part of the stabilisation to the funding announcement made in March 2025, which it says went some way to steadying goodwill values. Sellers who held on through 2024 were rewarded for it.
Thirty per cent of its transactions went to first-time buyers. That is a striking proportion for a regulated sector and it tells you the pharmacist-owner route into the market is genuinely open, not just theoretically available.
Across all the sectors Christie and Co covers, its price index moved 4.2% over the last twelve months on more than 1,000 completed transactions. Pharmacy is not an outlier in either direction.
How the number is usually built
Most pharmacy valuations are expressed as goodwill plus stock plus fixtures. Goodwill is typically anchored to dispensing volume and to sustainable profit, with the mix depending on who is buying: a corporate acquirer consolidating a region will look at what the site adds to its network, while an individual pharmacist buying their first shop is constrained by what a lender will advance against the earnings.
If you want the mechanics of turning an owner-managed profit and loss account into something a valuer will accept, our guide to normalising EBITDA covers the adjustments, and how to value a business sets out the wider framework.
The NHS contract is the asset
Here is the thing that catches out buyers arriving from unregulated sectors: you cannot simply buy a pharmacy and start dispensing NHS prescriptions. The right to provide NHS pharmaceutical services attaches to inclusion on the pharmaceutical list held by NHS England for the relevant area, and NHS England publishes consolidated lists quarterly through the NHS Business Services Authority.
Practically, that means three separate approvals sit between your offer and your first day of trading.
Inclusion on the pharmaceutical list. The NHS market entry regime controls who may provide NHS pharmaceutical services and where. A change of ownership is not automatic and it is not instant. The NHSBSA publishes an openings and closures dataset covering pharmacies included on a pharmaceutical list, which is worth checking for the area you are buying into.
GPhC registration of the premises. Registered pharmacy premises are regulated by the General Pharmaceutical Council, and the registration is tied to the owner. A change of ownership requires the new owner to register the premises.
A superintendent pharmacist. A body corporate owning a registered pharmacy must have a superintendent pharmacist in place. If you are not a pharmacist yourself, this is a recruitment problem you need solved before completion, not after.
None of this is exotic, and specialist pharmacy solicitors and agents deal with it every week. What it does is set the pace of the transaction. Christie and Co puts regulated sectors, pharmacy among them, at seven to ten months from accepted offer to completion against a five-month timeline for hospitality.
Plan your finances around the long end of that. A funding offer with a three-month expiry is not much use in a nine-month deal.
What to check before you commit
The generic buyer due diligence checklist applies. Layer these on top.
Start with the dispensing data
Item volume by month, three years, split NHS and private. Monthly matters. A pharmacy that dispensed 8,000 items a month for two years and 6,500 in the last six is telling you something the annual average hides. Ask what changed.
The prescribing relationships. Which GP practices generate the scripts, how far away are they, and is any surgery relocating, merging or closing? A pharmacy with one dominant feeder surgery is a single-point-of-failure business dressed up as a retail shop. Ask the same question about care homes, which can represent a large share of volume and can move to another provider on notice.
The pharmacy's mix beyond dispensing. Pharmacy First had delivered nearly five million consultations in its first year according to Christie and Co, and the NHSBSA data records 1.9 million items dispensed following those consultations in 2024/25. Service income, private clinics, travel vaccination and dispensing for care homes all carry different margins and different sustainability. Get them separated.
Then the things that survive completion
Staffing and cover. How many hours does the owner personally work as the responsible pharmacist, and what does replacing them cost? Locum rates can quietly remove a large slice of the profit you are buying. This is the single most common reason a pharmacy's stated earnings do not survive contact with a new owner.
Stock. Stock is valued separately at completion, usually by an independent stocktaker on the day. Agree the method in the heads of terms rather than arguing about it the night before.
The lease. Most pharmacies trade from leasehold premises, often with the landlord being the adjacent medical centre. Check the term, the rent review pattern and any break clauses, and check whether the lease restricts use in a way that would block a future sale.
Our list of questions worth putting to a seller covers the general ground, and liabilities you inherit explains what changes if you acquire the company rather than the assets.
The risks worth pricing in
Funding policy is the sector's weather. Community pharmacy income in England is dominated by a nationally negotiated settlement, and NHSBSA recorded £10.4bn of reimbursement costs in 2024/25, up 2%. Christie and Co credits the March 2025 announcement with stabilising goodwill values, and expects cost pressures to persist. Whatever your view of the direction, the point for a buyer is that a large part of your revenue is set by negotiation rather than by your own performance.
Consolidation cuts both ways. Corporate rationalisation continues, which means both competition for good sites and a supply of sites being disposed of by groups tidying their estates. Bank-driven and administrator-led sales remain part of the market. Those can be opportunities, and they can also be businesses with a reason for being where they are.
Location risk is structural. A pharmacy is only as good as the prescribing that flows past it. Check planning applications for new medical centres, and check whether any nearby surgery is part of a merger programme.
Distance selling changes the competitive set. Volume can leave a physical shop without anyone noticing until the monthly figures arrive.
Finding a pharmacy to buy
The UK pharmacy for sale market is heavily intermediated. A significant share of transactions never reach a public listing, because owners do not want staff or prescribing GPs to learn about a sale from a website. Registering with the specialist agents is not optional if you are serious.
At the same time, general marketplaces are where a growing share of independent sellers start, particularly those who do not want to pay a full brokerage fee. You can browse current listings on NewOwner — including regional markets in London, Manchester, Birmingham, and Scotland — and filter by sector and region.
Be specific about what you want before you start. Volume band, region, freehold or leasehold, and whether you will take on a business that needs turning around. Agents match specific briefs and ignore vague ones. Our guide to channels sellers actually use covers the channels in more detail, and how to buy a business in the UK walks through the process end to end.
If you are on the other side of this and thinking about an exit, the selling guide sets out what buyers in regulated sectors actually want to see, and business asset disposal relief covers the tax position.
The honest summary
Community pharmacy is a demanding sector to own and a defensible one to have bought well. Volume is rising, the number of competitors is falling, and the barriers to entry that make it slow to buy are the same barriers that protect you afterwards.
The two things that decide whether a specific deal works are the durability of the prescribing that feeds the site, and how much of the stated profit depends on the outgoing owner standing behind the counter unpaid. Get honest answers to both and the rest is process. Get lazy about either and the funding settlement will not save you. Before submitting an offer, benchmark goodwill and normalised EBITDA with our UK Business Valuation Calculator, download our Business Buyer Starter Kit to structure your regulatory checks, or learn more about NewOwner.
